Thursday, May 30, 2019 8:11:43 PM
I believe I have found it... Mr. Steven Giardino aka Pyrrhonian did not cover his tracks too well. He has been accused of causing problems on NWBO board: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=114167248 (archive: http://archive.is/BhF5Y)
And for Amarin, as well: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=128640054 (archive: http://archive.is/QVBgn)
I believe that this is his (de-activated) Seeking Alpha profile as well: https://seekingalpha.com/user/18578282/comments (archive: http://archive.is/3IuZX )
Note this comment from Feb 12, 2017 that jives with the iHub post above (100100)
iHub member Pyrrhonian admits to being “Steven Giardino”:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=118772141 (archive: http://archive.is/oQGO5 )
Now, why do I believe that Mr. Steven Giardino is behind MedicalResearchCollaborative, LLC?
Well, the domains (.org, .net, and .com) were all registered on 03/22/2019.
https://domain-status.com/www/medicalresearchcollaborative.org
https://domain-status.com/www/medicalresearchcollaborative.com
https://whois.icann.org/en/lookup?name=%20MedicalResearchCollaborative.com
This coincides with the creation of entity “MedicalResearchCollaborative, LLC” in the state of New Mexico, by a Mr. Steven Giardino on 03/22/2019:
Now, back to Mr. Steven Giardino.
He claims his mother’s maiden name is “O’Toole”: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=101523440 (archive: http://archive.is/jgMdd)
He has a daughter:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144792098 (http://archive.is/xhi3K)
Here he claims to be a contractor since 2003 doing remodels: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=98597930 (archive: http://archive.is/ila4U)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131023087 (archive: http://archive.is/JnNNb)
Here he claims to be a “former pre-med student with a degree in music”:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=108621919 (archive: http://archive.is/NHCJi)
Here he claims to have gambled at Poker on a “semi-pro” basis:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=121909028 (archive: http://archive.is/d74tk)
Note, here is an entry for a “professional” poker player named Steven Giardino from Albany, New York:
https://pokerdb.thehendonmob.com/player.php?a=r&n=596835 (archive: http://archive.is/7gEgs)
On the InvestorVillage boards, he goes by jmlogan72:
https://www.investorvillage.com/smbd.asp?mb=6543&mn=5156&pt=msg&mid=15864974 (archive: http://archive.is/66oZJ)
Here on iVillage, his post “And a kid from Albany who does remodeling work for a living just couldn't pass that up.” jives with the above information: https://www.investorvillage.com/smbd.asp?mb=6543&mn=7123&pt=msg&mid=16671343 (archive: http://archive.is/EMiqh)
Now, why would he do this? He’s been short from <$3:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124871839 (archive: http://archive.is/5FIvo )
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124828722 (archive: http://archive.is/K7dlS)
Interestingly, he and Kiwi discussed a construction remodel via email in August of 2016:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124528345 (archive: http://archive.is/075Cx)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=124529428 (archive: http://archive.is/Gplci)
Kiwi, do you know if Steven Giardino is actually his name, or an alias?
Also, I feel like this kind of activity (forming an LLC to specifically manipulate a publicly traded security) would run afoul of the SEC.
Recent AMRN News
- Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Europe • GlobeNewswire Inc. • 09/09/2024 11:30:00 AM
- Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress • GlobeNewswire Inc. • 08/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 09:30:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 08:54:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 11:05:34 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 11:05:26 AM
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 07/31/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 09:30:08 PM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024 • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR) • GlobeNewswire Inc. • 07/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM